GLP-1 Resource Center

What happens to your gut microbiome on Ozempic?

GLP-1 medications profoundly affect the gut in ways that extend well beyond the digestive symptoms most patients expect. The gut microbiome, the ecosystem of trillions of bacteria that govern digestion, immunity, and increasingly mood, is significantly disrupted by the way GLP-1 medications alter how the gut functions.

How GLP-1 medications affect the gut environment

GLP-1 medications slow gastric emptying, the rate at which food moves from the stomach into the small intestine and onward through the colon. The gut microbiome evolved in an environment of regular food transit. When transit slows significantly, the conditions that beneficial bacteria depend on change.

Reduced dietary diversity compounds the disruption

The gut microbiome is fed by the diversity of food consumed. When food intake drops significantly and dietary variety narrows, the microbiome loses the nutritional diversity it needs to maintain population balance. The result is dysbiosis, an imbalanced microbiome that contributes to the bloating, gas, constipation, and digestive discomfort many GLP-1 patients experience.

The TAKE approach

TAKE Flora delivers 40 billion CFU of clinically studied probiotic strains using MAKTREK Bi-Pass Technology, a patented marine polysaccharide delivery system that protects probiotic cultures through stomach acid. Alongside TAKE Flow for digestive motility support, both form the core of The Gut Reset System.

These statements have not been evaluated by the Food and Drug Administration. TAKE products are not intended to diagnose, treat, cure, or prevent any disease. Always consult your healthcare provider before starting any new supplement.